CHEBI:94793 - pimasertib

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name pimasertib
ChEBI ID CHEBI:94793
Definition A secondary carboxamide resulting from the formal condensation of the carboxy group of 3-(2-fluoro-4-iodoanilino)pyridine-4-carboxylic acid with the amino group of (2S)-3-aminopropane-1,2-diol. It is a potent inhibitor of the mitogen-activated protein kinases MEK1 and MEK2 with potential antineoplastic activity.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
more structures >>
Formula C15H15FIN3O3
Net Charge 0
Average Mass 431.206
Monoisotopic Mass 431.01421
InChI InChI=1S/C15H15FIN3O3/c16-12-5-9(17)1-2-13(12)20-14-7-18-4-3-11(14)15(23)19-6-10(22)8-21/h1-5,7,10,20-22H,6,8H2,(H,19,23)/t10-/m0/s1
InChIKey VIUAUNHCRHHYNE-JTQLQIEISA-N
SMILES OC[C@@H](O)CNC(=O)C1=C(NC2=C(F)C=C(I)C=C2)C=NC=C1
Roles Classification
Chemical Role(s): Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
Biological Role(s): EC 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor
An EC 2.7.12.* [dual-specificity kinases (those acting on Ser/Thr and Tyr residues)] inhibitor that inhibits the action of mitogen-activated protein kinase kinase (EC 2.7.12.2).
apoptosis inducer
Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
Application(s): antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing pimasertib (CHEBI:94793) has role antineoplastic agent (CHEBI:35610)
pimasertib (CHEBI:94793) has role apoptosis inducer (CHEBI:68495)
pimasertib (CHEBI:94793) has role EC 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor (CHEBI:88286)
pimasertib (CHEBI:94793) is a aminopyridine (CHEBI:38207)
pimasertib (CHEBI:94793) is a difluorobenzene (CHEBI:38582)
pimasertib (CHEBI:94793) is a diol (CHEBI:23824)
pimasertib (CHEBI:94793) is a primary alcohol (CHEBI:15734)
pimasertib (CHEBI:94793) is a pyridinecarboxamide (CHEBI:25529)
pimasertib (CHEBI:94793) is a secondary alcohol (CHEBI:35681)
pimasertib (CHEBI:94793) is a secondary carboxamide (CHEBI:140325)
pimasertib (CHEBI:94793) is a substituted aniline (CHEBI:48975)
IUPAC Name
N-[(2S)-2,3-dihydroxypropyl]-3-(2-fluoro-4-iodoanilino)pyridine-4-carboxamide
INNs Sources
pimasertib WHO MedNet
pimasertib WHO MedNet
pimasertib WHO MedNet
pimasertibum WHO MedNet
Synonyms Sources
AS 703026 ChEBI
AS-703026 ChEBI
AS703026 ChEBI
MSC 1936369B ChEBI
MSC-1236369B ChEBI
MSC1936369B ChEBI
N-[(2S)-2,3-dihydroxypropyl]-3-(2-fluoro-4-iodoanilino)-4-pyridinecarboxamide ChEBI
SAR 245509 ChEBI
SAR-245509 ChEBI
SAR245509 ChEBI
Manual Xrefs Databases
D10426 KEGG DRUG
DB14904 DrugBank
LSM-5946 LINCS
QOA PDBeChem
View more database links
Registry Number Type Source
1236699-92-5 CAS Registry Number KEGG DRUG
Citations Waiting for Citations Types Sources
20331454 PubMed citation Europe PMC
24051957 PubMed citation Europe PMC
25989270 PubMed citation Europe PMC
26033306 PubMed citation Europe PMC
26381508 PubMed citation Europe PMC
26444523 PubMed citation Europe PMC
26640591 PubMed citation Europe PMC
26657199 PubMed citation Europe PMC
26924269 PubMed citation Europe PMC
26961147 PubMed citation Europe PMC
27179113 PubMed citation Europe PMC
27179114 PubMed citation Europe PMC
27483391 PubMed citation Europe PMC
27934635 PubMed citation Europe PMC
28151716 PubMed citation Europe PMC
28194539 PubMed citation Europe PMC
28289865 PubMed citation Europe PMC
29338133 PubMed citation Europe PMC
29488172 PubMed citation Europe PMC
29756206 PubMed citation Europe PMC
30425349 PubMed citation Europe PMC
30585255 PubMed citation Europe PMC
30848427 PubMed citation Europe PMC
31482223 PubMed citation Europe PMC
31586300 PubMed citation Europe PMC
31870556 PubMed citation Europe PMC
32610581 PubMed citation Europe PMC
33170484 PubMed citation Europe PMC
33211315 PubMed citation Europe PMC
34470822 PubMed citation Europe PMC
37097377 PubMed citation Europe PMC
Last Modified
14 June 2024